Skip to main content
logo
Vilin Bio Med Limited (NSE:VILINBIO)
India flag India · Delayed Price · Currency is INR
51.00
-1.95 (-3.68%)
Oct 7, 2026, 3:21 PM IST

Vilin Bio Med Financials Overview

Millions INR. Fiscal year is Apr - Mar.

Revenue & Profits
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Revenue
422.63422.63148.1158.05123.37112.19
Revenue Growth
111.52%185.37%-6.30%28.11%9.97%-4.26%
Gross Profit
46.0846.0813.1427.7450.7422.42
Operating Income
29.129.16.856.8724.35.51
Net Income
19.2919.292.241.6212.450.34
Earnings Per Share
1.261.260.160.121.250.04
EPS Growth
600.89%687.50%37.44%-90.69%3025.00%-72.80%

Cash & Debt
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Investments
14.714.70.5660.490.350.39
Total Debt
2.062.0625.7368.349.3153
Net Cash (Debt)
12.6412.64-25.17-7.81-48.97-52.61
Net Cash Growth
------
Net Cash Per Share
0.830.83-1.80-0.56-4.92-6.38

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Cash Flow
6.986.982.15-74.21-16.592.09
Capital Expenditures
-2.97-2.97-15.75-0.01-0.3-
Free Cash Flow
4.014.01-13.6-74.22-16.882.09
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Gross Margin
10.90%10.90%8.87%17.55%41.13%19.98%
Operating Margin
6.88%6.88%4.63%4.34%19.70%4.91%
Pretax Margin
6.72%6.72%2.07%1.42%14.44%0.40%
Profit Margin
4.56%4.56%1.51%1.03%10.09%0.30%
FCF Margin
0.95%0.95%-9.18%-46.96%-13.68%1.86%

Valuation
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingOct '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PE Ratio
42.0226.51127.27163.21--
P/FCF Ratio
201.37127.50----
PS Ratio
1.911.211.921.68--